Human Anti-RSV F Recombinant Antibody (TP-098CL) (CAT#: TP-098CL)
Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV). This antibody is a composite of human (95%) and murine (5%) antibody sequences. The human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2). The human light chain sequence was derived from the constant domain of Ck and the variable framework regions of the VL gene K104 withJk-4. The antibody is expressed from a stable murine (mouse) myeloma cell line (NS0).It is composed of to heavy chains (50.6 kDa each) and two light chains (27.6 kDa each), contains 1-2% carbohydrate by weight and has a molecular weight of 147.7 kDa +/- 1 kDa.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Specifications
- Type
- Biotech
Target
- Function
- Humanized igG1 mAb that binds the A antigenic site of the F protein of respiratory syncytial virus
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
Q&As
Customer Review
-
Q 1: Is there any genetic engineering involved in the production of this antibody?
A: Yes, this antibody is produced by recombinant DNA technology, featuring 95% human and 5% murine antibody sequences that enhance specificity and performance consistency.
-
Q 2: Does the antibody contain any endotoxins?
A: The regular batch production does not include endotoxin removal. However, high-purity processes ensure low endotoxin levels suitable for most research applications.
-
Q 3: What makes this antibody ideal for RSV research?
A: Its specificity to the RSV F protein and humanized design make it an excellent tool for studying RSV pathogenesis and developing antiviral strategies.
View the frequently asked questions answered by Creative Biolabs Support.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TP-098CL, RRID: AB_3112054)
Copy citation
Popular products with customers
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: ELISA, IP, WB, IHC, IF, FuncS
-YJ-3.jpg)
Application: ELISA
Application: FC, IHC-Fr, IP, ELISA, Block
-3.jpg)
Application: Neut
Application: ELISA, FuncS, Neut, IF, WB, EM, Inhib, IHC
-2.png)
Application: WB, ELISA, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
